DOI: 10.1055/s-00000134

Diabetologie und Stoffwechsel

References

Roden M, Weng J, Eilbracht J. et al.
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet Diabetes Endocrinol 2013;
1: 208-219

Download Bibliographical Data

Access: